Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

6.24
BATS BZX Real-Time Price
As of 12:44pm ET
 +0.375 / +6.40%
Today’s Change
4.08
Today|||52-Week Range
15.01
-25.69%
Year-to-Date
Better Buy: Novavax, Inc. vs. Pfizer Inc.
May 30 / MotleyFool.com - Paid Partner Content
Billionaire George Soros' Fund Bought These Stocks: Should You?
May 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close5.86
Today’s open5.99
Day’s range5.96 - 6.28
Volume271,978
Average volume (3 months)6,950,627
Market cap$1.6B
Dividend yield--
Data as of 12:44pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-59.85%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.33+3.01%
RDUSRadius Health Inc+0.87+2.48%
OPHTOphthotech Corp+2.45+4.80%
HALOHalozyme Therapeutic...+0.19+1.90%
Data as of 12:44pm ET, 05/31/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior Vice President-
Quality Operations
Robert Darius
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers

Search for Jobs